Healthcare contacts# and care costs by deprivation quintile in the Salford Lung Study (SLS) of COPD and SLS asthma (total study populations)
| Deprivation quintile¶ | SLS COPD (N=2791) | SLS asthma (N=4218) | ||||||
| Annual number of healthcare contacts+ mean±sd | Total COPD care costs per patient§ £ geometric mean±sd | Annual number of healthcare contacts+ mean±sd | Total COPD care costs per patient§ £ geometric mean±sd | |||||
| FF/VI (n=1396) | UC (n=1395) | FF/VI (n=1396) | UC (n=1395) | FF/VI (n=2105) | UC (n=2113) | FF/VI (n=2105) | UC (n=2113) | |
| 1 | n=731 32.0±23.4 | n=722 29.4±22.2 | n=731 842.1±2.3 | n=722 981.4±2.1 | n=412 20.0±19.0 | n=443 18.8±17.0 | n=412 417.3±1.8 | n=443 453.7±1.9 |
| 2 | n=307 29.7±21.8 | n=294 28.4±21.8 | n=307 742.5±2.1 | n=294 984.1±2.1 | n=434 18.1±15.0 | n=400 18.5±17.6 | n=434 412.9±1.8 | n=400 433.3±1.9 |
| 3 | n=189 29.9±19.0 | n=202 28.4±20.3 | n=189 819.0±2.0 | n=202 955.2±2.1 | n=401 17.0±14.8 | n=455 17.0±14.6 | n=401 411.0±1.6 | n=455 479.7±1.9 |
| 4 | n=104 29.2±19.3 | n=105 27.4±18.6 | n=104 730.7±1.9 | n=105 894.8±2.0 | n=425 16.0±13.7 | n=406 13.2±11.6 | n=425 431.3±1.8 | n=406 431.6±1.9 |
| 5 | n=65 27.5±22.4 | n=72 21.3±14.9 | n=65 743.4±2.0 | n=72 823.6±1.8 | n=433 14.2±12.6 | n=409 13.2±11.4 | n=433 419.7±1.8 | n=409 427.8±1.8 |
FF/VI: fluticasone furoate/vilanterol; UC: usual care. #: on-treatment, all-cause healthcare contacts; ¶: where 1 is the most deprived and 5 is the least deprived; +: composite analysis of all primary and secondary healthcare contacts; §: including total direct costs for COPD/asthma-related healthcare resource utilisation, rescue medication and study drugs.